Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
Fernandez CV, Mullen EA, Chi YY, Ehrlich PF, Perlman EJ, Kalapurakal JA, Khanna G, Paulino AC, Hamilton TE, Gow KW, Tochner Z, Hoffer FA, Withycombe JS, Shamberger RC, Kim Y, Geller JI, Anderson JR, Grundy PE, Dome JS. Fernandez CV, et al. Among authors: kalapurakal ja. J Clin Oncol. 2018 Jan 20;36(3):254-261. doi: 10.1200/JCO.2017.73.7999. Epub 2017 Dec 6. J Clin Oncol. 2018. PMID: 29211618 Free PMC article.
Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study.
Kletzel M, Katzenstein HM, Haut PR, Yu AL, Morgan E, Reynolds M, Geissler G, Marymount MH, Liu D, Kalapurakal JA, Shore RM, Bardo DM, Schmoldt J, Rademaker AW, Cohn SL. Kletzel M, et al. Among authors: kalapurakal ja. J Clin Oncol. 2002 May 1;20(9):2284-92. doi: 10.1200/JCO.2002.06.060. J Clin Oncol. 2002. PMID: 11980999 Clinical Trial.
Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study Group.
Kalapurakal JA, Li SM, Breslow NE, Beckwith JB, Macklis R, Thomas PR, D'Angio GJ, Kim T, de Lorimier A, Kelalis P, Shochat S, Ritchey M, Haase G, Hrabovsky E, Otherson HB, Grundy P, Green DM; National Wilms' Tumor Study Group. Kalapurakal JA, et al. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):495-9. doi: 10.1016/s0360-3016(03)00598-4. Int J Radiat Oncol Biol Phys. 2003. PMID: 12957262 Clinical Trial.
Management of Wilms' tumour: current practice and future goals.
Kalapurakal JA, Dome JS, Perlman EJ, Malogolowkin M, Haase GM, Grundy P, Coppes MJ. Kalapurakal JA, et al. Lancet Oncol. 2004 Jan;5(1):37-46. doi: 10.1016/s1470-2045(03)01322-6. Lancet Oncol. 2004. PMID: 14700607 Review.
Radiation therapy for favorable histology Wilms tumor: prevention of flank recurrence did not improve survival on National Wilms Tumor Studies 3 and 4.
Breslow NE, Beckwith JB, Haase GM, Kalapurakal JA, Ritchey ML, Shamberger RC, Thomas PR, D'Angio GJ, Green DM. Breslow NE, et al. Among authors: kalapurakal ja. Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):203-9. doi: 10.1016/j.ijrobp.2005.11.029. Epub 2006 Mar 20. Int J Radiat Oncol Biol Phys. 2006. PMID: 16542795 Free PMC article.
122 results